XOMA to Present at BIO 2005 Annual International Conference
Monday June 13, 1:00 pm ET
BERKELEY, Calif.--(BUSINESS WIRE)--June 13, 2005--XOMA Ltd. (Nasdaq:XOMA - News) today announced that Tom Smart, vice president of business development, will provide an overview of XOMA's business strategy and partnering opportunities at the BIO 2005 Annual International Conference in Philadelphia, PA on June 21, 2005 at 3:00 p.m., eastern time. Mr. Smart's presentation is part of the conference's BIO Business Forum.
About XOMA
XOMA develops and commercializes antibody and other protein-based biopharmaceuticals for cancer, immune disorders and infectious diseases. The company pipeline includes products from collaborative product development programs with Chiron Corporation, Millennium Pharmaceuticals, Inc., and Aphton Corporation, and also includes RAPTIVA®, a product marketed worldwide that came from a collaboration with Genentech, Inc. For more information about XOMA's product pipeline and antibody product development capabilities and technologies, please visit XOMA's website at www.xoma.com. |
